160134-88-3 Usage
Uses
Used in Organic Synthesis:
(2S,3R)-2-tert-butoxycarbonylamino-3-(2-nitrophenoxy)butyric acid is used as a key intermediate in organic synthesis for the development of complex organic molecules and pharmaceuticals. Its unique structure and functional groups allow for versatile chemical reactions and modifications, facilitating the creation of novel compounds with potential applications in various industries.
Used in Drug Development:
In the pharmaceutical industry, (2S,3R)-2-tert-butoxycarbonylamino-3-(2-nitrophenoxy)butyric acid is used as a building block for the design and synthesis of new drugs. Its specific stereochemistry and functional groups can be leveraged to create molecules with targeted biological activities, potentially leading to the development of innovative therapeutic agents for various diseases and conditions.
Used as a Research Reagent:
(2S,3R)-2-tert-butoxycarbonylamino-3-(2-nitrophenoxy)butyric acid serves as a valuable research reagent in scientific studies. Its unique structure and properties make it an ideal tool for investigating biological processes, enzyme mechanisms, and molecular interactions. Researchers can use (2S,3R)-2-tert-butoxycarbonylamino-3-(2-nitrophenoxy)butyric acid to probe the structure-activity relationships of related molecules and gain insights into the underlying principles of biological systems.
Check Digit Verification of cas no
The CAS Registry Mumber 160134-88-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,0,1,3 and 4 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 160134-88:
(8*1)+(7*6)+(6*0)+(5*1)+(4*3)+(3*4)+(2*8)+(1*8)=103
103 % 10 = 3
So 160134-88-3 is a valid CAS Registry Number.
160134-88-3Relevant academic research and scientific papers
SUBSTITUTED HETERO-AZEPINONES
-
Page/Page column 59, (2014/03/21)
There are provided compounds of the formula (1) wherein W, X, Y, Z, R1, R2, R3, R4, R5 and R6 are described herein. These compounds are useful for the treatment of proliferative diseases, including cancer.
Malonamide derivatives
-
Page/Page column 20, (2010/11/08)
The invention relates to compounds of the formula I wherein R, R1, R2, R3, X, and n are defined in the specification. The invention also provides pharmaceutically suitable acid addition salts thereof and all forms of optically pure enantiomers, recemates or diastereomers and diastereomeric mixtures thereof. Compounds of the invention are useful for the treatment of Alzheimer's disease.
